Linda Ohrmund

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Niels Vande Casteele, Reena Khanna, Barrett G. Levesque et al. · Gut · 2014 · 283 citations · Full text

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

Shui-Long Wang, Linda Ohrmund, Scott Hauenstein et al. · Journal of Immunological Methods · 2012 · 203 citations · Full text

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

Barrett G. Levesque, Gordon R. Greenberg, Guangyong Zou et al. · Alimentary Pharmacology & Therapeutics · 2014 · 100 citations · Full text

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Shui-Long Wang, Scott Hauenstein, Linda Ohrmund et al. · Journal of Pharmaceutical and Biomedical Analysis · 2013 · 80 citations · Full text

Analytical Validation, Homogeneous Mobility Shift, Immunology +23